Insider Transaction Report for ACADIA PHARMACEUTICALS INC

2026-05-27SEC Filing 4 (0001816160-26-000008)

James Kihara, Principal Accounting Officer of ACADIA PHARMACEUTICALS INC, reported a sale of 5,401 shares of common stock on May 26, 2026. The shares were sold at a weighted average price of $21.18, with individual sale prices ranging from $21.1801 to $21.185. Following this transaction, Kihara holds 24,509 shares. This report also notes the acquisition of 781 shares by Kihara on May 15, 2026, through an employee stock purchase plan.